A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants

Clinical trial NCT05852340 · COMPLETED

Trial details

NCT number: NCT05852340
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Adult Pharmacokinetics

Start date: 2023-05-09
Primary completion: 2023-06-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.